Advertisement

This Popular Stock Has a 93% Upside, According to Wall Street

This Popular Stock Has a 93% Upside, According to Wall Street

If you had invested in Novavax (NASDAQ: NVAX) at the beginning of 2020, you'd be sitting pretty right now. Novavax's efforts to develop and market a vaccine for COVID-19 explain the company's terrific performance of late. The company's average price target of $264.20 implies gains of 93% from its share price of $136.86 as of this writing.